High-Dose Daptomycin for Staphylococcus aureus Infections
Author Information
Author(s): Schaad Heinz J, Bento Manuela, Lew Daniel P, Vaudaux Pierre
Primary Institution: Geneva University Hospital
Hypothesis
High-dose daptomycin will be more effective than standard treatments for chronic Staphylococcus aureus infections.
Conclusion
Daptomycin at a twice-daily dose of 30 mg/kg significantly reduced bacterial counts more than oxacillin or vancomycin in a rat model of infection.
Supporting Evidence
- Daptomycin showed a more rapid in vitro elimination of MSSA strain I20 compared to oxacillin and vancomycin.
- The twice-daily regimen of daptomycin resulted in significantly higher reductions in viable counts than the other antibiotics.
- Daptomycin maintained bactericidal levels in infected cage fluids throughout the therapy.
Takeaway
This study found that giving a lot of daptomycin helps fight off a tough infection better than other antibiotics.
Methodology
Rats were infected with Staphylococcus aureus and treated with daptomycin, oxacillin, or vancomycin for 7 days, with bacterial counts measured before and after treatment.
Limitations
The study was conducted in a rat model, which may not fully replicate human responses.
Participant Demographics
Rats were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website